Sub-visible particles pose detection challenge; Elan launches scale-up, manufacturing services;

> Some of the recent drug recalls stemming from particle contamination--one involving sub-visible, 25- to 30-micron particles--highlight inspection and contamination control challenges. Article

> Drug delivery specialist Elan has launched a manufacturing services business encompassing drug product optimization, scale-up, and commercial-scale manufacturing of solid oral dosage forms. Elan release

> Police and health officials in Bangkok, following a tip, raided four drug stockrooms, two of which operate as pharmacies, and found more than 200 varieties of fake pharmaceuticals, unauthorized generics and illegal imports. Article

> Supplier relationship management is as vital an aspect of drug supply chain security technology tools e-pedigree, RFID and spectroscopy. Article

> Contract manufacturer SAFC has completed a 50,000-square-foot expansion of its Jerusalem facility, increasing its capacity to make recombinant proteins and small molecule APIs, including high-potency materials and secondary metabolites. SAFC release

> Bormioli Rocco says it can produce molded glass vials with "optimum glass distribution and an approximate weight reduction of 30% compared to conventional vials." Bormioli Rocco release

> NextPharma has announced the start of construction of a cold chain and logistics warehouse in Werne, Germany. NextPharma release

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.